The polyaneuploid cancer cell state mediates multitherapy resistance in cancer
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210680
- Recipient
-
The Johns Hopkins University UEI FTMTDMBR29C7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,170,746
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Baltimore, MD 21218, USA
Award details come from USAspending.gov.
About this award
The Johns Hopkins University was awarded a $1,170,746 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to investigate the polyaneuploid cancer cell state and its role in mediating multitherapy resistance in cancer. The three-year award, effective August 15, 2022 through August 14, 2025, will support research into transforming healthcare for service members and the public through innovative biomedical research solutions for battlefield medicine. A sub-award of $150,000 was provided to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to support delivery of related products and services under this funding.
Quick answers
Who received award W81XWH2210680?
W81XWH2210680 was awarded to The Johns Hopkins University by Medical Command (Department of the Army) on August 15, 2022.
How much is award W81XWH2210680 worth?
$1,170,746 has been obligated on W81XWH2210680.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award